Outrageous! - Artificial Deflation! Speaking of deflation, let me mention something I find totally outrageous. Normally, I actually take up for the bureaucrats who are stuck with the task of trying to monitor inflation. It is a tough job, and like Monday-morning quarterbacks, everybody thinks you should have done it…
A Trip Back in Time to Profit from the Unfolding Crisis Today By Doug Casey and David Galland At one point or another in your life, you’ve probably fantasized about going back in time. Such fantasies typically involve visions of truckloads of easy money. From, say, buying beachfront property in…
And if you subscribe today, you also can get the recently released and widely praised Conversation I did with Donald Coxe and Gary Shilling on commodities and where those markets are going. That ended up as a very powerful debate, and one from which listeners said they really came away…
…you do is simply subscribe to David's Dividend Café, a brief daily market update plus a short philosophical point. I have been reading him daily for years. I have literally known him for decades, as he was a kid when I published his extraordinarily brilliant seminary professor father’s rather dense…
…observers asking me to subscribe to their work. Believe me they weren’t cheap. I would not send somebody a check for $3000 to give me ideas or elucidate areas of the market that I may have overlooked. I was supposed to learn on my own. Do the work myself. Nobody…
…Jared Dillian If you subscribe to The Daily Dirtnap, one of my other publications, you have probably been reading about how I am not super excited about stocks at the moment. (Note: The time to be super excited about them was October of last year.) Not calling for a crash—no…
…is go ahead and subscribe to their service. As I said, I find it essential reading. I talked George’s staff into a 50% discount this week, or only $199 a year or $19.95 a month. The link I have below will get redirected to the correct site. You get a…
…and associates, recommending they subscribe. I am often asked by readers and other writers to speculate on why the letter has been as successful as it has. While there is no one answer, I do have a few thoughts. First, it is free. The price is right, so to speak.…
Want a New Cardiovascular System? Seven weeks ago, on January 3, the father of stem cell medicine made an announcement that will be remembered forever by historians. Dr. Michael West, CEO of BioTime Inc., launched a subsidiary, ReCyte Therapeutics, to commercialize endothelial stem cell therapies to reverse senescence in the…
John Mauldin
John Mauldin